Lorvotuzumab Biosimilar - Anti-CD56,NCAM1 mAb - Research Grade, Human Humanized, Monoclonal
Artikelnummer:
PTG-PX-TA1047-1MG
- Bilder (0)
| Artikelname: | Lorvotuzumab Biosimilar - Anti-CD56,NCAM1 mAb - Research Grade, Human Humanized, Monoclonal |
| Artikelnummer: | PTG-PX-TA1047-1MG |
| Hersteller Artikelnummer: | PX-TA1047-1MG |
| Alternativnummer: | PTG-PX-TA1047-1MG |
| Hersteller: | ProteoGenix |
| Wirt: | Human Humanized |
| Kategorie: | Antikörper |
| Spezies Reaktivität: | Human |
| Alternative Synonym: | Anti-CD56, Anti-NCAM1, Anti-NCAM-1, BB-10901, IMGN901, huN901-DM1, CAS: 1008106-64-6 |
| Klonalität: | Monoclonal |
| UniProt: | P13591 |
| Puffer: | 0.01M PBS, pH 7.4. |
| Expression System: | Eukaryotic expression |
| Target-Kategorie: | CD56/NCAM1 |
Produktgarantie und fachkundiger Support
